Form 4 filings across 5 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$5.4M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
1 of 18 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 3 business days late.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured
The 55 most recent Form 4 transactions.
| Jun 26 | NTRA | Natera, Inc. | AGRANT | 1,571 | — | — | +8.5% | Open the original filing on SEC.gov |
| Jun 12 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 4,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 12 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 4,500 | $50.00 | $225K | -9.8% | Open the original filing on SEC.gov |
| Jun 12 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 4,500 | $21.38 | $96.2K | +10.8% | Open the original filing on SEC.gov |
| May 19 | TVTX | Travere Therapeutics, Inc. | AGRANT◆ | 12,000 | — | — | — | Open the original filing on SEC.gov |
| May 19 | TVTX | Travere Therapeutics, Inc. | AGRANT | 4,000 | — | — | +10.7% | Open the original filing on SEC.gov |
| May 15 | NRIX | Nurix Therapeutics, Inc. | AGRANT◆ | 31,250 | — | — | — | Open the original filing on SEC.gov |
| May 5 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 4,500 | — | — | — | Open the original filing on SEC.gov |
| May 5 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 4,500 | $46.65 | $209.9K | -10.7% | Open the original filing on SEC.gov |
| May 5 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 4,500 | $18.27 | $82.2K | +12.0% | Open the original filing on SEC.gov |
| May 1 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 9,750 | — | — | — | Open the original filing on SEC.gov |
| May 1 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 9,750 | $44.22 | $431.1K | -20.6% | Open the original filing on SEC.gov |
| May 1 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 9,750 | $6.82 | $66.5K | +26.0% | Open the original filing on SEC.gov |
| Apr 24 | NTRA | Natera, Inc. | AGRANT | 83 | — | — | +0.4% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 6,750 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 4,500 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 4,500 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 9,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 8,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 6,750 | $42.12 | $284.3K | -15.3% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 26,000 | $41.07 | $1.1M | -37.0% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 6,750 | $17.11 | $115.5K | +10.6% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 4,500 | $21.38 | $96.2K | +7.6% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 4,500 | $18.27 | $82.2K | +8.3% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 9,000 | $15.43 | $138.9K | +19.8% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 8,000 | $17.94 | $143.5K | +21.3% | Open the original filing on SEC.gov |
| Apr 6 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 6 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 10,000 | $33.00 | $330K | -21.1% | Open the original filing on SEC.gov |
| Apr 6 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 10,000 | $26.52 | $265.2K | +26.7% | Open the original filing on SEC.gov |
| Mar 2 | EIKN | Eikon Therapeutics, Inc. | AGRANT◆ | 134,088 | — | — | — | Open the original filing on SEC.gov |
| Jan 30 | NTRA | Natera, Inc. | AGRANT | 70 | — | — | +0.4% | Open the original filing on SEC.gov |
| Nov 20, 2025 | NTRA | Natera, Inc. | MEXER◷◆ | 7,068 | — | — | — | Open the original filing on SEC.gov |
| Nov 20, 2025 | NTRA | Natera, Inc. | MEXER◷◆ | 600 | — | — | — | Open the original filing on SEC.gov |
| Nov 20, 2025 | NTRA | Natera, Inc. | SSELL◷ | 1,884 | $224.89 | $423.7K | -9.3% | Open the original filing on SEC.gov |
| Nov 20, 2025 | NTRA | Natera, Inc. | SSELL◷ | 1,900 | $223.90 | $425.4K | -8.6% | Open the original filing on SEC.gov |
| Nov 20, 2025 | NTRA | Natera, Inc. | SSELL◷ | 1,800 | $222.90 | $401.2K | -7.5% | Open the original filing on SEC.gov |
| Nov 20, 2025 | NTRA | Natera, Inc. | SSELL◷ | 900 | $221.81 | $199.6K | -3.6% | Open the original filing on SEC.gov |
| Nov 20, 2025 | NTRA | Natera, Inc. | SSELL◷ | 1,184 | $220.14 | $260.6K | -4.5% | Open the original filing on SEC.gov |
| Nov 20, 2025 | NTRA | Natera, Inc. | MEXER◷ | 7,068 | $41.19 | $291.1K | +37.3% | Open the original filing on SEC.gov |
| Nov 20, 2025 | NTRA | Natera, Inc. | MEXER◷ | 600 | $40.93 | $24.6K | +3.3% | Open the original filing on SEC.gov |
| Nov 19, 2025 | NTRA | Natera, Inc. | MEXER◷◆ | 5,112 | — | — | — | Open the original filing on SEC.gov |
| Nov 19, 2025 | NTRA | Natera, Inc. | SSELL◷ | 2,135 | $216.07 | $461.3K | -10.4% | Open the original filing on SEC.gov |
| Nov 19, 2025 | NTRA | Natera, Inc. | SSELL◷ | 1,727 | $214.79 | $370.9K | -7.8% | Open the original filing on SEC.gov |
| Nov 19, 2025 | NTRA | Natera, Inc. | SSELL◷ | 1,250 | $213.47 | $266.8K | -5.3% | Open the original filing on SEC.gov |
| Nov 19, 2025 | NTRA | Natera, Inc. | MEXER◷ | 5,112 | $40.93 | $209.2K | +27.8% | Open the original filing on SEC.gov |
| Oct 31, 2025 | NTRA | Natera, Inc. | AGRANT | 93 | — | — | +0.5% | Open the original filing on SEC.gov |
| Jul 25, 2025 | NTRA | Natera, Inc. | AGRANT | 108 | — | — | +0.6% | Open the original filing on SEC.gov |
| Jun 27, 2025 | NTRA | Natera, Inc. | AGRANT | 2,143 | — | — | +13.4% | Open the original filing on SEC.gov |
| Jun 11, 2025 | AARD | Aardvark Therapeutics,… | AGRANT◆ | 30,508 | — | — | — | Open the original filing on SEC.gov |
| May 19, 2025 | NRIX | Nurix Therapeutics, Inc. | AGRANT◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| May 15, 2025 | TVTX | Travere Therapeutics, Inc. | AGRANT◆ | 19,500 | — | — | — | Open the original filing on SEC.gov |
| May 15, 2025 | TVTX | Travere Therapeutics, Inc. | AGRANT | 6,500 | — | — | +21.0% | Open the original filing on SEC.gov |
| Apr 25, 2025 | NTRA | Natera, Inc. | AGRANT | 116 | — | — | +0.7% | Open the original filing on SEC.gov |